Inve India ▾

Evexia Lifecare share price & results

EVEXIA LIFECARE LIMITED· Chemicals· Commodities

Results to
Sept 2026
Ownership as of
Sept 2026

Gujarat-based manufacturer and trader of pharmaceuticals, chemicals and lifecare products, with majority stakes in edible-oil, diagnostics, testing-lab and BPO group companies.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue25.0 ₹ crore−2.8% YoYQuarterly, as filedQuarter to Sept 2026Revenue from operations as filed.
Operating margin-0.3 %−0.7 pts YoYOperating profit / revenueQuarter to Sept 2026For the quarter; a change is in percentage points.
Net profit0.23 ₹ crore−37.8% YoYQuarterly, as filedQuarter to Sept 2026Profit after tax as filed.
Return on equity0.36 %+0.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-23.85 %−21.9 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)26.64 %−28.9 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2026

Price

₹1.65 −4.62% · −₹0.08

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −11.3% 1Y

₹0.50₹1.00₹1.50₹2.00Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26

1Y: ₹1.86 on 24 Oct 2025 → ₹1.65. High ₹2.24 (14 Oct 2026), low ₹0.49 (2 Apr 2026).

Previous close
₹1.73
Market cap
₹237 Cr
52-week range
₹0.49 – ₹2.24
One year
−6.78%
Price to earnings (TTM to Sept 2026)
137.79×
Return on equity (TTM to Sept 2026)
0.36%

Overview

Symbol
NSE:EVEXIA
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What EVEXIA LIFECARE LIMITED does

Based on the company's own presentations, annual report and earnings calls.

Evexia Lifecare Limited manufactures and trades in pharmaceuticals, chemicals and lifecare products. Beyond this core business, the company holds majority equity stakes in a cluster of group companies spanning edible-oil processing (Kavit Edible Oil Limited, 80%), diagnostic centres (Vittal's MediCare Private Limited, 51%), chemical/biological testing and research services (Revin Labs Private Limited, 50%), pharmaceuticals and chemicals trading (Diponed Bio Private Limited, 65%), and business-process outsourcing (Kavit Trading Private Limited, 70%).

Segments

  • Pharmaceuticals, chemicals & lifecare products
  • Edible oil
  • Diagnostics
  • Chemical/biological testing & research
  • Pharma & chemicals trading
  • Business process outsourcing (BPO/KPO)
Majority-owned group companies
5 (edible oil, diagnostics, testing labs, pharma trading, BPO/KPO)
Stake in Kavit Edible Oil Limited (edible oil)
80%
Stake in Kavit Trading Private Limited (BPO/KPO)
70%
Stake in Diponed Bio Private Limited (pharma/chemicals trading)
65%
Stake in Vittal's MediCare Private Limited (diagnostic centres)
51%
Stake in Revin Labs Private Limited (testing & research)
50%
Founded 1990Headquarters Vadodara, Gujarat Company website

Your own record

Start an Inve Case for EVEXIA LIFECARE LIMITED

Free account: one company. Everything above stays public.

Write why you follow EVEXIA LIFECARE LIMITED and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse EVEXIA LIFECARE LIMITED

Guides on how to read this kind of business and the numbers that matter.